Tag: AstraZeneca
Over 1bn COVID-19 vaccines reserved by European Union
With its latest deal with Johnson & Johnson (J&J) for 400 million doses of its potential COVID-19 vaccine, the European Union (EU) seems to...
AstraZeneca could earn vaccine profits soon: Deal documents
AstraZeneca, the UK-based pharmaceutical firm, which said it would not make profit from the vaccine during the pandemic period, could start earning from its...
Japan resumes Oxford COVID-19 vaccine trials: US continues to halt
Even as the US authorities continue to persist with the abrupt halt for AstraZeneca-Oxford University COVID-19 vaccine candidate trials, Japan became the latest country...
Oxford COVID vaccine nearing approval? European rolling review expected soon
European authorities are reportedly considering to expedite the entire vaccine approval process by conducting an accelerated review of the Oxford-AstraZeneca COVID-19 vaccine candidate.
European agency...
US Oxford COVID-19 vaccine trails remain halted: FDA clearance pending
Oxford University's COVID-19 vaccine candidate trials still remain halted in the United States as an investigation into a serious side effect reported in the...
Oxford COVID-19 vaccine cleared to resume trails
After a brief halt, Oxford University's COVID-19 vaccine candidate has been cleared by UK authorities to resume clinical trials.
An independent safety review committee...
Oxford COVID vaccine trial stopped; Company releases statement
Advanced trials for one of the most promising COVID-19 vaccine candidates co-developed by AstraZeneca and Oxford University been put on hold across the globe.
British-Swedish...
India to get Oxford COVID Vaccine first; Reports
India could be the first country to conduct mass immunization drive for its citizens using British pharma giant AstraZeneca's potential COVID-19 vaccine developed by...
